OPTIMIZING THE TIMING OF NIPT BASED ON MULTI-FACTOR REGRESSION AND DECISION ANALYTICS
Keywords:
NIPT, Fetal fraction, Gestational age, Body mass index, Regression modeling, Decision optimizationAbstract
Noninvasive prenatal testing (NIPT) is widely used for screening common fetal aneuploidies, but its reliability is strongly affected by fetal fraction and is often reduced in pregnant women with elevated body mass index (BMI). This study develops an integrated statistical and optimization framework to generate practical recommendations on testing timing under heterogeneous maternal characteristics and sequencing quality conditions. Using real-world NIPT records from male fetal samples, Y chromosome concentration was adopted as a proxy for fetal signal adequacy, and qualification was defined by the empirical threshold of Y ≥ 4%. First, multivariate regression and weighted least squares were used to quantify the joint effects of gestational age and BMI on Y chromosome concentration and to derive a closed-form qualification probability. Second, BMI-stratified logistic models were constructed to estimate the earliest gestational week required to achieve a target qualification probability, such as 90%, and to reveal systematic timing delays associated with increasing BMI. Third, a risk-based optimization strategy was applied to generate a smooth BMI-dependent timing trajectory by explicitly balancing non-qualification risk against delay cost, and robustness was assessed through perturbation-based resampling. Finally, a multi-factor logistic generalized linear model incorporating maternal age, weight, unique aligned reads, and GC content was established, and joint optimization of BMI boundaries and testing times was used to eliminate infeasible extreme-BMI subgroups and improve group-level fairness. The proposed framework translates observational associations into deployable timing recommendations and provides quantitative support for individualized NIPT timing decisions.References
[1] American College of Obstetricians and Gynecologists. Practice bulletin no 226: Screening for fetal chromosomal abnormalities. Obstetrics and Gynecology, 2020, 136(4): e48-e69.
[2] Hui L, Bianchi D W. Fetal fraction and noninvasive prenatal testing: What clinicians need to know. Prenatal Diagnosis, 2020, 40(2): 155-163.
[3] Pan Xiaoli, Pan Yun, Li Haibo. Factors affecting low fetal cell-free DNA concentration and its relationship with pregnancy outcomes. Chinese Journal of Prenatal Diagnosis, 2023, 15(4): 18-21.
[4] Xue Ying, Ding Jie, He Quanze, Wang Ting. Effects of maternal age, gestational age and body mass index on fetal cell-free DNA fraction in maternal peripheral blood. Chinese Journal of Prenatal Diagnosis, 2017, 9(3): 5-10.
[5] Chen Pengyu, Zhang Quanfu. Factors affecting fetal cell-free DNA concentration in noninvasive prenatal testing and research progress on clinical applications. Advances in Clinical Medicine, 2024, 14(10): 1182-1192.
[6] Muzzey D, Goldberg J D, Haverty C. Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk. Prenatal Diagnosis, 2020, 40(3): 333-341.
[7] Liu Cheng, Wang Yipeng, Zou Liying, et al. Factors influencing failure of repeat sampling in noninvasive prenatal testing and its impact on pregnancy outcomes. Chinese Journal of Obstetrics and Gynecology, 2025, 60(4): 268-274.
[8] Xing Qianling, Liu Hongqian. Factors affecting fetal cell-free DNA concentration and discussion on related prenatal screening and diagnostic strategies. Chinese Journal of Prenatal Diagnosis, 2023, 15(3): 11-19.
[9] Wei Zhifang, Hou Dongxia, Wang Xiaohua. Research progress on factors affecting fetal cell-free DNA concentration in noninvasive prenatal screening. Laboratory Medicine and Clinic, 2025, 22(6): 850-854,859.
[10] Van Beek D M, Straver R, Weiss M M, et al. Comparing methods for fetal fraction determination and quality control of NIPT samples. Prenatal Diagnosis, 2017, 37(8): 769-773.
[11] Suzumori N, Sekizawa A, Ebara T, et al. Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2021, 256: 75-81.
[12] Miceikaitė I, Brasch-Andersen C, Fagerberg C, et al. Total number of reads affects the accuracy of fetal fraction estimates in NIPT. Molecular Genetics and Genomic Medicine, 2021, 9(4): e1653.
[13] Qiao L, Mao J, Liu M, et al. Experimental factors are associated with fetal fraction in size selection noninvasive prenatal testing. American Journal of Translational Research, 2019, 11(10): 6370-6381.